Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map Gene description Filtered Network Comparison Type green Rank network_comparison red
Results: HTML CSV LaTeX Showing element 1 to 50 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1
Network Comparison Type: Divided
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent red\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2765.82\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 60\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.6231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4489.19\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 8630.06\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 509\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.14278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7551.8\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 8636.87\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 508\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.14293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7556.75\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 8532.02\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 514\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.1411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7477\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 8543.66\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 513\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.14143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7485.08\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 (ec 3.1.4.11) (phosphoinositide phospholipase c) (plc-beta-4) (phospholipase c-beta-4). [source:swissprot;acc:q15147]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3126\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6303.92\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1136\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.08864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5790.65\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 10-formyltetrahydrofolate dehydrogenase (ec 1.5.1.6) (10-fthfdh). [source:swissprot;acc:o75891]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6262.07\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5812.02\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 14-3-3 protein epsilon (mitochondrial import stimulation factor l subunit) (protein kinase c inhibitor protein-1) (kcip-1) (14-3-3e). [source:swissprot;acc:p42655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 14-3-3 protein zeta/delta (protein kinase c inhibitor protein-1) (kcip-1) (factor activating exoenzyme s) (fas). [source:swissprot;acc:p29312]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6265.44\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.0774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5815.33\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 14.5 kda translational inhibitor protein (p14.5) (uk114 antigen homolog). [source:swissprot;acc:p52758]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6788.96\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1600\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07145\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6336.22\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6933.36\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1043\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.09283\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6344.41\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 15-hydroxyprostaglandin dehydrogenase [nad(+)] (ec 1.1.1.141) (pgdh). [source:swissprot;acc:p15428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2855\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6113.96\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.02511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5964.17\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2-hydroxyphytanoyl-coa lyase (ec 4.1.-.-) (2-hpcl) (hspc279). [source:swissprot;acc:q9uj83]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6192.72\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1393\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5743.36\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2-oxoglutarate dehydrogenase e1 component, mitochondrial precursor (ec 1.2.4.2) (alpha-ketoglutarate dehydrogenase). [source:swissprot;acc:q02218]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6362.25\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2506\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.0261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6200.39\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6957.34\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2451\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.03268\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6737.15\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component beta chain) (bckdh e1-beta). [source:swissprot;acc:p21953]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6048.94\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.04585\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5783.76\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5843.51\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 107\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.36977\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4266.04\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3079\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit 4 (p26s4). [source:swissprot;acc:q03527]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6376.76\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07379\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5938.56\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit 6a (tat-binding protein 1) (tbp-1) (proteasome subunit p50). [source:swissprot;acc:p17980]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6362.33\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1527\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07349\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5926.76\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6242.94\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1567\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07226\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5822.25\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit 7 (mss1 protein). [source:swissprot;acc:p35998]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6207.5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1539\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5783.97\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit 8 (proteasome subunit p45) (thyroid hormone receptor interacting protein 1) (trip1) (msug1 protein) (tat-binding protein homolog 10) (tbp10) (p45/sug). [source:swissprot;acc:p47210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 9234.09\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.00914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9150.44\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6349.04\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1577\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5923.66\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 1 (26s proteasome regulatory subunit s1) (26s proteasome subunit p112). [source:swissprot;acc:q99460]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6195.48\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1883\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.06342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5826\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6242.44\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07134\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5826.74\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6271.79\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1592\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07153\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5853.1\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6261.87\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1579\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07179\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5842.44\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6278.32\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1585\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07166\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5858.48\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6980.13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.08451\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6436.19\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6244.37\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1546\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07303\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5819.39\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5800.97\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5475.74\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6435.42\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1472\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07535\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5984.47\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit s12) (proteasome subunit p40) (mov34 protein homolog). [source:swissprot;acc:p51665]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6273.4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07208\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5851.64\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 8 (26s proteasome regulatory subunit s14) (p31). [source:swissprot;acc:p48556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6350.53\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1536\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5916.05\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 9 (26s proteasome regulatory subunit p27). [source:swissprot;acc:o00233]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6439.46\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1517\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.07393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5996.14\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 26s proteasome-associated pad1 homolog. [source:refseq;acc:nm\_005805]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6186.39\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1643\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.06977\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5782.92\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5583.64\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2720\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.00351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5603.24\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s12, mitochondrial precursor (mpr-s12) (mt- rps12). [source:swissprot;acc:o15235]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3381.34\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2153\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.05302\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3560.63\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 5510.67\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1955\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.0607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5195.3\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 28492\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 115\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.34491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 21185\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s18a, mitochondrial precursor (mrp-s18-a) (mrps18a) (mrp-s18-3). [source:swissprot;acc:q9nvs2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6218.77\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 835\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.10592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5623.18\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s26, mitochondrial precursor (mrp-s26) (mrp- s13). [source:swissprot;acc:q9byn8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6797.24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2071\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.05592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6437.24\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28s ribosomal protein s9, mitochondrial precursor (mrp-s9). [source:swissprot;acc:p82933]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3788.42\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 2530\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.02431\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3880.5\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 3 beta-hydroxy-delta 5-c27-steroid oxidoreductase. [source:refseq;acc:nm\_025193]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 3147\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 0.00001\vspace{3pt}}}\\\cline{1-1}\cline{3-3} \parbox{\wcA}{\vspace{3pt}\noindent 3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 2756\vspace{3pt}}&&\\\cline{1-1}\cline{3-3} \parbox{\wcA}{\vspace{3pt}\noindent 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type i (3beta-hsd i) (trophoblast antigen fdo161g) [includes: 3-beta-hydroxy- delta(5)-steroid dehydrogenase (ec 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (progesterone reductase); steroid delta- isomerase (ec 5.3.3.1) (delta-5-3-ketosteroid isomerase)]. [source:swissprot;acc:p14060]\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 2802\vspace{3pt}}&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/